Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2,500 | 1 | 99.6% |
| Food and Beverage | $10.60 | 1 | 0.4% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $2,511 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2017 | $2,511 | 2 | Merck Sharp & Dohme Corporation ($2,511) |
All Payment Transactions
2 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/26/2017 | Merck Sharp & Dohme Corporation | DULERA (Drug) | — | Cash or cash equivalent | $2,500.00 | Research |
| Study: A 26-Week Randomized, Double-Blinded, Active Controlled Study Comparing the Safety of Mometasone Furoate,Formoterol Fumarate MDI Fixed Dose Combination Versus Mometasone Furoate MDI Monotherapy in Adolescents and Adults With Persistent Asthma Protocol No. P06241 also known as P202 • Category: RESPIRATORY | ||||||
| 05/04/2017 | Merck Sharp & Dohme Corporation | NUVARING (Drug), NEXPLANON | Food and Beverage | In-kind items and services | $10.60 | General |
| Category: WOMENS HEALTH | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A 26-Week Randomized, Double-Blinded, Active Controlled Study Comparing the Safety of Mometasone Furoate,Formoterol Fumarate MDI Fixed Dose Combination Versus Mometasone Furoate MDI Monotherapy in Adolescents and Adults With Persistent Asthma Protocol No. P06241 also known as P202 | Merck Sharp & Dohme Corporation | $2,500 | 1 |
About Dr. Lydia Oftadeh, MD
Dr. Lydia Oftadeh, MD is a Specialist healthcare provider based in Cudahy, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1912964255.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lydia Oftadeh, MD has received a total of $2,511 in payments from pharmaceutical and medical device companies, with $2,511 received in 2017. These payments were reported across 2 transactions from 1 company. The most common payment nature is "" ($2,500).
Practice Information
- Specialty Specialist
- Location Cudahy, CA
- Active Since 04/28/2006
- Last Updated 07/08/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1912964255
Products in Payments
- DULERA (Drug) $2,500
- NUVARING (Drug) $10.60
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.